GlassScriptPhysician profile
Aaron Gustin
NPI 1730536129
$11,537.42
in general payments reported to CMS, 2019-2025
8 companies · $9,048 in 2025
The $9,048 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.85 · 2024: $2,440 · 2025: $9,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,897 · Travel and Lodging: $1,142 · Food and Beverage: $889 · Education: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,896.67 |
| Travel and Lodging | $1,141.94 |
| Food and Beverage | $888.99 |
| Education | $559.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $9,336.65 | 2024-2025 | |
| Penumbra, INC. | $1,362.30 | 2025 | Penumbra System |
| Stryker Corporation | $312.22 | 2024-2025 | Target, Surpass Evolve, Axs Vecta 71 |
| Medtronic, INC. | $234.80 | 2024-2025 | Pipeline, Strata, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Abbott Laboratories | $160.00 | 2025 | Xact |
| Globus Medical, INC. | $53.68 | 2025 | Creo, Excelsius Gps, Sable |
| Medtronic USA, INC. | $49.85 | 2019 | |
| Microvention, INC. | $27.92 | 2024 | Web Aneurysm Embolization System, Stent, Lvis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Gustin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.